SUPRIYA LIFESCIENCE
Back to Income Statement
|
SUPRIYA LIFESCIENCE Last 5 Year Revenue History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹828 Cr | ₹696 Cr | ₹570 Cr | ₹461 Cr | ₹530 Cr |
What is the latest Revenue of SUPRIYA LIFESCIENCE ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹828 Cr |
| Mar2025 | ₹696 Cr |
| Mar2024 | ₹570 Cr |
| Mar2023 | ₹461 Cr |
| Mar2022 | ₹530 Cr |
How is Revenue of SUPRIYA LIFESCIENCE Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹828 Cr | 18.86 | |
| Mar2025 | ₹696 Cr | 22.12 | |
| Mar2024 | ₹570 Cr | 23.73 | |
| Mar2023 | ₹461 Cr | -13.04 | |
| Mar2022 | ₹530 Cr | - | |
Compare Revenue of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹6,884.4 Cr | 7% | -4% | 27.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | 7% |
-4% |
27.1% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses